DK412489A - Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren - Google Patents

Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren

Info

Publication number
DK412489A
DK412489A DK412489A DK412489A DK412489A DK 412489 A DK412489 A DK 412489A DK 412489 A DK412489 A DK 412489A DK 412489 A DK412489 A DK 412489A DK 412489 A DK412489 A DK 412489A
Authority
DK
Denmark
Prior art keywords
leukocytadhaesion
alfa
mac
receptor
substances
Prior art date
Application number
DK412489A
Other languages
English (en)
Other versions
DK412489D0 (da
Inventor
Timothy Alan Springer
Angel Corbi
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of DK412489D0 publication Critical patent/DK412489D0/da
Publication of DK412489A publication Critical patent/DK412489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK412489A 1988-08-23 1989-08-22 Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren DK412489A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23535388A 1988-08-23 1988-08-23
US32123989A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
DK412489D0 DK412489D0 (da) 1989-08-22
DK412489A true DK412489A (da) 1990-02-24

Family

ID=26928829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK412489A DK412489A (da) 1988-08-23 1989-08-22 Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren

Country Status (13)

Country Link
US (3) US5849896A (da)
EP (1) EP0364690A3 (da)
JP (1) JPH0347077A (da)
KR (1) KR0185964B1 (da)
AU (1) AU638937B2 (da)
CA (1) CA1341293C (da)
DK (1) DK412489A (da)
FI (1) FI893917L (da)
HU (1) HU213014B (da)
IL (1) IL91370A (da)
NO (1) NO893367L (da)
NZ (1) NZ230397A (da)
PT (1) PT91502B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US5877275A (en) * 1988-06-28 1999-03-02 The General Hospital Corporation Controlling cellular immune/inflammatory responses with β2 integrins
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
ZA901842B (en) * 1989-03-09 1990-12-28 Boehringer Ingelheim Pharma Use of intercellular adhesion molecules,and their binding ligans in the treatment of asthma
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
AU674556B2 (en) * 1992-10-09 1997-01-02 Center For Blood Research, Inc., The A subpopulation of MAC-1 molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
EP0758393A1 (en) * 1994-04-26 1997-02-19 PHARMACIA & UPJOHN COMPANY Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
AU2964295A (en) * 1994-07-11 1996-02-09 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
US5696229A (en) * 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
US6037454A (en) * 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US7400477B2 (en) 1998-08-24 2008-07-15 Leviton Manufacturing Co., Inc. Method of distribution of a circuit interrupting device with reset lockout and reverse wiring protection
US6210897B1 (en) 1999-05-26 2001-04-03 Leif Andersson Identification of canine leukocyte adhesion deficiency in dogs
JP2003527439A (ja) 2000-03-17 2003-09-16 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 抗ｃｄ１８抗体と抗ｃｃｒ２抗体の混合物を用いる狭窄および再狭窄を抑制する方法
ATE448306T1 (de) * 2000-09-01 2009-11-15 Blood Res Center Veränderte, in gewünschter konformation stabilisierte polypeptide und verfahren zu deren herstellung
US7852606B2 (en) * 2005-08-24 2010-12-14 Leviton Manufacturing Company, Inc. Self-testing circuit interrupting device
US7372678B2 (en) * 2005-08-24 2008-05-13 Leviton Manufacturing Co., Inc. Circuit interrupting device with automatic test
US7911746B2 (en) * 2006-06-01 2011-03-22 Leviton Manufacturing Co., Inc. GFCI with self-test and remote annunciation capabilities
US8603628B2 (en) * 2007-04-30 2013-12-10 Saint-Gobain Performance Plastics Corporation Turbine blade protective barrier
CN101910856B (zh) * 2008-01-29 2014-06-18 立维腾制造有限公司 自测试故障电路中断器装置和方法
US9759758B2 (en) 2014-04-25 2017-09-12 Leviton Manufacturing Co., Inc. Ground fault detector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5424399A (en) * 1988-06-28 1995-06-13 The Children's Medical Center Corporation Human CR3α/β heterodimers
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor

Also Published As

Publication number Publication date
KR0185964B1 (ko) 1999-05-01
EP0364690A2 (en) 1990-04-25
IL91370A0 (en) 1990-04-29
FI893917A0 (fi) 1989-08-21
US20030013850A1 (en) 2003-01-16
AU638937B2 (en) 1993-07-15
JPH0347077A (ja) 1991-02-28
US5849896A (en) 1998-12-15
HUT54207A (en) 1991-01-28
NO893367L (no) 1990-02-26
DK412489D0 (da) 1989-08-22
PT91502B (pt) 1995-05-04
HU213014B (en) 1997-01-28
FI893917A7 (fi) 1990-02-24
EP0364690A3 (en) 1990-07-18
IL91370A (en) 1995-07-31
FI893917L (fi) 1990-02-24
KR900002797A (ko) 1990-03-23
US20020022595A1 (en) 2002-02-21
US6683158B2 (en) 2004-01-27
NZ230397A (en) 1997-07-27
NO893367D0 (no) 1989-08-22
PT91502A (pt) 1990-03-08
CA1341293C (en) 2001-09-18
AU4014489A (en) 1990-03-01

Similar Documents

Publication Publication Date Title
DK412489D0 (da) Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren
FI874804A7 (fi) Bisykliset yhdisteet.
DK272589D0 (da) Blandingsapparat
FI931314A7 (fi) Monikomponenttinen rakenne-elin
NO895010L (no) Konstruksjonsmateriale.
DK295889A (da) Fremgangsmaade til sammenklaebning af materialelag
BR8704567A (pt) Composicao de resina termofixavel
FI912378A0 (fi) Sekoituslaite
DE68909432D1 (de) Direkte fixierung von geflochtenen strukturen.
DE68927655D1 (de) Analog-Digital-Wandler
TR24653A (tr) Aciloksinitrojen perasit iptidai maddeler
BR8703792A (pt) Composicao de resina
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
BR8703314A (pt) Material de friccao
FR2596792B1 (fr) Element de construction autoverrouillable
BR8706749A (pt) Conjunto de construcao
FI892469L (fi) Sekaraaka-aineista valmistettuja absorboivia rakenteita
DK541487A (da) Sammenfoejning af materialer
DK318689A (da) Anvendelse af lactamimider til fremstilling af calcium-antagonister
KR900008475U (ko) 진개 제거기
KR900000655U (ko) 물통의 뚜껑
DK621088D0 (da) Theemballage af theposetypen
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
FR2637306B1 (fr) Element de construction
DK164273C (da) Affaldsbeholder

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment